ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2169

Reporting of Adverse Events in Randomized Controlled Trials of Therapeutic Exercise for Knee Osteoarthritis: A Systematic Review

Johan vonHeideken 1 and Maura D. Iversen2, 1Karolinska Institutet, Stockholm, Sweden, 2Northeastern University, Boston

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: adverse events and exercise, Knee osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Orthopedics, Low Back Pain, & Rehabilitation Poster – ACR/ARP

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: CONSORT guidelines recommend the reporting of adverse events (AEs) and drop outs, along with a description of each. However, the application of these guidelines in clinical trials of exercise is unknown. This study aimed to identify how AEs and drop outs are reported in clinical trials of therapeutic exercise for adults with KOA.

Methods: Cochrane Library, EMBASE, MEDLINE, and CINAHL databases were searched to identify randomized controlled trials of therapeutic exercise for patients with KOA published in English from January 1, 1980 through December 31, 2016. The American Physical Therapy Association operational definition of therapeutic exercise was used. Databases were searched  using the following search terms: knee osteoarthritis AND exercise OR exercise therapy OR strengthening OR aerobics OR anaerobic OR dynamic OR isotonic OR isometric OR isokinetic OR strengthening OR aquatic OR physical therapy AND clinical trial NOT modalities. Studies which compared non-pharmacologic interventions to therapeutic exercise were eligible as long as the therapeutic exercise intervention arm included only therapeutic exercise. Studies which included patients with other forms of arthritis or with non-specified knee pain were excluded. We focused on studies which reported outcomes related to impairments, functional limitations and participation. Four researchers independently examined each study and eliminated studies which did not meet our inclusion criteria. The reference list for each chosen article was also screened for eligible studies. In instances where the eligibility of the study was unclear, the researchers deliberated and came to a consensus regarding inclusion. Using a standardized form, we extracted information regarding participant and intervention characteristics, whether there was a clear statement of AEs and drop outs and reasons for AEs and drop outs. Study quality was assessed using the PEDRO scoring method and descriptive and inferential statistics were used to characterize results.

Results: One hundred two studies from 21 countries met the inclusion criteria with 6,654 subjects exercising. Of these 102 studies, 32 studies (31%) included a statement of AEs and 14 of these studies (44%) reported AEs. Eighty-five studies (83%) had a clear statement regarding drop outs and 20 studies (23%) gave reasons for drop out that could be classified as AEs. Forty percent of studies published in North America and Western Europe had a statement of AEs compared to 25% of studies from the rest of the world (p=0.13). Adverse events were reported for 59 patients and 55 individuals dropped out for reasons that could be considered an AEs, yielding 114 patients (2%) experiencing an AE-related to exercise.

Conclusion: Overall the quality of included studies was good. Geographic variations existed in statements about AEs. AEs and drop outs may be underreported and not sufficiently represent the risk associated with therapeutic exercise. Greater clarity regarding definitions of AEs and adherence to the CONSORT reporting guidelines are needed to best determine safe dosing of therapeutic exercise for KOA.


Updated- PRIMSA flow figure-5.24.19


ACRabstractTables.Summary of AE Reporting in Clinical Trials


Disclosure: J. vonHeideken, None; M. Iversen, Pfizer, 2, Swedish Rheumatism, 2, Norrebacca Eugenia Foundation, 2.

To cite this abstract in AMA style:

vonHeideken J, Iversen M. Reporting of Adverse Events in Randomized Controlled Trials of Therapeutic Exercise for Knee Osteoarthritis: A Systematic Review [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/reporting-of-adverse-events-in-randomized-controlled-trials-of-therapeutic-exercise-for-knee-osteoarthritis-a-systematic-review/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reporting-of-adverse-events-in-randomized-controlled-trials-of-therapeutic-exercise-for-knee-osteoarthritis-a-systematic-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology